Literature DB >> 27928590

Complement C3a levels and misinterpretation of classifier technology.

Mario Petretta1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 27928590     DOI： 10.1007/s00011-016-1016-0

Source DB:  PubMed          Journal:  Inflamm Res        ISSN： 1023-3830            Impact factor:   4.575


× No keyword cloud information.
  6 in total

1.  A note on the evaluation of novel biomarkers: do not rely on integrated discrimination improvement and net reclassification index.

Authors:  Jørgen Hilden; Thomas A Gerds
Journal:  Stat Med       Date:  2013-04-02       Impact factor: 2.373

Review 2.  Prediction models for risk classification in cardiovascular disease.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-10-03       Impact factor: 9.236

3.  Complement C3a predicts outcome in cardiac resynchronization therapy of heart failure.

Authors:  Gábor Széplaki; András Mihály Boros; Szabolcs Szilágyi; István Osztheimer; Zsigmond Jenei; Annamária Kosztin; Klaudia Vivien Nagy; Júlia Karády; Levente Molnár; Tamás Tahin; Endre Zima; László Gellér; Zoltán Prohászka; Béla Merkely
Journal:  Inflamm Res       Date:  2016-08-04       Impact factor: 4.575

4.  Net reclassification improvement and integrated discrimination improvement require calibrated models: relevance from a marker and model perspective.

Authors:  Maarten J G Leening; Ewout W Steyerberg; Ben Van Calster; Ralph B D'Agostino; Michael J Pencina
Journal:  Stat Med       Date:  2014-08-30       Impact factor: 2.373

Review 5.  Net reclassification improvement: computation, interpretation, and controversies: a literature review and clinician's guide.

Authors:  Maarten J G Leening; Moniek M Vedder; Jacqueline C M Witteman; Michael J Pencina; Ewout W Steyerberg
Journal:  Ann Intern Med       Date:  2014-01-21       Impact factor: 25.391

6.  Assessing the performance of prediction models: a framework for traditional and novel measures.

Authors:  Ewout W Steyerberg; Andrew J Vickers; Nancy R Cook; Thomas Gerds; Mithat Gonen; Nancy Obuchowski; Michael J Pencina; Michael W Kattan
Journal:  Epidemiology       Date:  2010-01       Impact factor: 4.822
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.